A detailed history of Newfound Research LLC transactions in Stryker Corp stock. As of the latest transaction made, Newfound Research LLC holds 411 shares of SYK stock, worth $149,850. This represents 0.2% of its overall portfolio holdings.

Number of Shares
411
Previous 442 7.01%
Holding current value
$149,850
Previous $88,000 5.68%
% of portfolio
0.2%
Previous 0.19%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 13, 2022

SELL
$189.27 - $231.83 $5,867 - $7,186
-31 Reduced 7.01%
411 $83,000
Q2 2022

Jul 15, 2022

SELL
$194.09 - $276.37 $26,202 - $37,309
-135 Reduced 23.4%
442 $88,000
Q1 2022

May 04, 2022

BUY
$245.33 - $277.77 $8,831 - $9,999
36 Added 6.65%
577 $154,000
Q4 2021

Jan 19, 2022

BUY
$236.63 - $276.44 $25,792 - $30,131
109 Added 25.23%
541 $145,000
Q3 2021

Oct 14, 2021

BUY
$248.9 - $280.09 $65,709 - $73,943
264 Added 157.14%
432 $114,000
Q2 2021

Jul 19, 2021

BUY
$242.95 - $267.0 $40,815 - $44,856
168 New
168 $44,000

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $138B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Newfound Research LLC Portfolio

Follow Newfound Research LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newfound Research LLC, based on Form 13F filings with the SEC.

News

Stay updated on Newfound Research LLC with notifications on news.